Cosmos Health Inc.
As of Oct 22, 2026, Cosmos Health is in Stage 1, the basing phase, now in week 7 (since Sep 10, 2026). It closed at $0.25, 75.4% below its 52-week high and below its 200-day average, which is falling.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is COSM early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
COSM among Medical Distribution8th of 11 by relative strength
All 11 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | FOCL | Stage 4 · wk 1 | 92 | −12.4% |
| 2 | CAH | Stage 2 · wk 1 | 90 | +15.8% |
| 3 | HSIC | Stage 3 · wk 1 | 79 | +1.1% |
| 4 | MCK | Stage 2 · wk 7 | 76 | +15.0% |
| 5 | COR | Stage 2 · wk 4 | 58 | +8.4% |
| 6 | AHG | Stage 4 · wk 16 | 36 | +58.4% |
| 7 | YI | Stage 4 · wk 16 | 32 | −17.3% |
| 8 | COSM | Stage 1 · wk 7 | 13 | −37.8% |
Cosmos Health: quick answers
What stage is Cosmos Health in?
As of Oct 22, 2026, Cosmos Health (COSM) is in Stage 1, the basing phase. It entered Stage 1 on Sep 10, 2026 and is in week 7. What the four stages mean
Is Cosmos Health in an uptrend?
Not yet. Cosmos Health is in Stage 1, a base that can come before an uptrend. It trades 20.6% below its 200-day average, which is falling.
How far is Cosmos Health from its 52-week high?
Cosmos Health closed at $0.25 on Oct 22, 2026, 75.4% below its 52-week high of $1.03. Its 52-week low is $0.17.
How has Cosmos Health performed over the past year?
As of Oct 22, 2026, Cosmos Health is down 75.9% over the past year and down 50.9% so far in 2026.
Which sector and industry is Cosmos Health in?
Cosmos Health is in the Medical Distribution industry, part of the Health Care sector.
About this companyHealth Care· Medical Distribution
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.